Ohcanbohtosat - Axel Finckh
- Čájehuvvo 1 - 20 / 55
- Sirdás čuovvovaš siidui
-
1
-
2
The impact of obesity on the development and progression of rheumatoid arthritis Dahkki Axel Finckh, Carl Turesson
Almmustuhtton 2014Carta -
3
-
4
-
5
-
6
-
7
-
8
Cigarette smoking and radiographic progression in rheumatoid arthritis Dahkki Axel Finckh, Silvia Dehler, Karen H. Costenbader, Cem Gabay
Almmustuhtton 2007Artigo -
9
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network... Dahkki Felicity Buckley, Axel Finckh, T. Huizinga, F. Dejonckheere, Jeroen P. Jansen
Almmustuhtton 2015Revisão -
10
-
11
Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study Dahkki Burkhard Möller, Almut Scherer, Frauke Förger, Peter M. Villiger, Axel Finckh
Almmustuhtton 2013Artigo -
12
-
13
-
14
Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort Dahkki R Mueller, T. Kaegi, Axel Finckh, Sarah R. Haile, Hendrik Schulze‐Koops, J. von Kempis
Almmustuhtton 2013Artigo -
15
Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis Dahkki Sophie Martin Du Pan, Silvia Dehler, Adrian Ciurea, Hans‐Rudolf Ziswiler, Cem Gabay, Axel Finckh
Almmustuhtton 2009Artigo -
16
-
17
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an a... Dahkki Axel Finckh, Adrian Ciurea, Laure Brulhart, Burkhard Möller, Ulrich A. Walker, D. Courvoisier, Diego Kyburz, Jean Dudler, Cem Gabay
Almmustuhtton 2009Artigo -
18
-
19
-
20
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis Dahkki Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia, Laura Martinez Prat, Michael Mähler, Chelsea Bentow, Axel Finckh, Cem Gabay, Michael J. Nissen
Almmustuhtton 2020Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Rheumatoid arthritis
Disease
Physical therapy
Immunology
Arthritis
Environmental health
Population
Cohort
Rituximab
Antirheumatic Agents
Observational study
Pathology
Rheumatology
Adalimumab
Adverse effect
Lymphoma
Tofacitinib
Alternative medicine
Biology
Computer science
Etanercept
Gastroenterology
Intensive care medicine
Oncology
Surgery
Abatacept
Clinical trial
Confounding